Search Results

Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the Face: An Open-Label Study

Authors: >Muge Guler Ozden,; >Nilgun Solak Tekin,; İlter, Nilsel; Ankarali, Handan

Source: American Journal of Clinical Dermatology, Volume 11, Number 1, 1 February 2010 , pp. 51-54(4)

Publisher: Adis International

Outpatient care and medical treatment of children and adults with atopic eczema

Authors: Schmitt, Jochen; Schmitt, Natalie M.; Kirch, Wilhelm; Meurer, Michael

Source: Journal der Deutschen Dermatologischen Gesellschaft, Volume 7, Number 4, April 2009 , pp. 345-351(7)

Publisher: Blackwell Publishing

Role of the epidermal barrier in atopic dermatitis

Authors: Proksch, Ehrhardt; Fölster-Holst, Regina; Bräutigam, Matthias; Sepehrmanesh, Marjan; Pfeiffer, Stephan; Jensen, Jens-Michael

Source: Journal der Deutschen Dermatologischen Gesellschaft, Volume 7, Number 10, October 2009 , pp. 899-910(12)

Publisher: Blackwell Publishing

Topical use of pimecrolimus in atopic dermatitis: Update on the safety and efficacy

Author: Werfel, Thomas

Source: Journal der Deutschen Dermatologischen Gesellschaft, Volume 7, Number 9, September 2009 , pp. 739-742(4)

Publisher: Blackwell Publishing

Topische Anwendung von Pimecrolimus bei atopischer Dermatitis: Ein Update zur Sicherheit und Wirksamkeit

Author: Werfel, Thomas

Source: Journal der Deutschen Dermatologischen Gesellschaft, Volume 7, Number 9, September 2009 , pp. 739-743(5)

Publisher: Blackwell Publishing

Vitiligo therapy

Authors: Lotti, Torello; Berti, Samantha; Moretti, Silvia

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 17, December 2009 , pp. 2779-2785(7)

Publisher: Informa Healthcare

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis

Authors: Yang, Lily P.H.; Curran, Monique P.

Source: Pediatric Drugs, Volume 11, Number 6, 1 December 2009 , pp. 407-426(20)

Publisher: Adis International

Twice-daily versus Once-daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis

Authors: Ruer-Mulard, Mireille; Aberer, Werner; Gunstone, Anthony; Kekki, Outi-Maria; Estebaranz, Jose Luis López; Vertruyen, André; Guettner, Achim; Hultsch, Thomas

Source: Pediatric Dermatology, Volume 26, Number 5, September/October 2009 , pp. 551-558(8)

Publisher: Blackwell Publishing

Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment

Authors: Nissi, R.; Kotila, V.; Knuuti, E.; Väre, P.O.; Kauppila, S.

Source: British Journal of Dermatology, Volume 161, Number 4, October 2009 , pp. 958-960(3)

Publisher: Blackwell Publishing

A survey of vitiligo management among dermatologists in Saudi Arabia

Author: AlGhamdi, KM

Source: Journal of the European Academy of Dermatology & Venereology, Volume 23, Number 11, November 2009 , pp. 1282-1288(7)

Publisher: Blackwell Publishing

Pimecrolimus: a new choice in the treatment of vitiligo?

Authors: Eryılmaz, A; Seçkin, D; Baba, M

Source: Journal of the European Academy of Dermatology & Venereology, Volume 23, Number 11, November 2009 , pp. 1347-1348(2)

Publisher: Blackwell Publishing

Facial acne during topical pimecrolimus therapy for vitiligo

Authors: Li, J.-C.; Xu, A.-E.

Source: Clinical & Experimental Dermatology, Volume 34, Number 7, October 2009 , pp. e489-e490(1)

Publisher: Blackwell Publishing

Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study

Authors: Barikbin, B.; Givrad, S.; Yousefi, M.; Eskandari, F.

Source: Clinical & Experimental Dermatology, Volume 34, Number 7, October 2009 , pp. 776-780(5)

Publisher: Blackwell Publishing

Insight into pimecrolimus experience in seborrheic dermatitis: Close follow-up with exact mean cure and remission times and side-effect profile

Authors: Tatlican, Semih; Eren, Cemile; Eskioglu, Fatma

Source: Journal of Dermatological Treatment, Volume 20, Number 4, August 2009 , pp. 198-202(5)

Publisher: Informa Healthcare

Use of topical corticosteroids is associated with an increased risk of lymphoma

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 4-4(1)

Publisher: Adis International

Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial

Authors: Leung, D.Y.M.; Hanifin, J.M.; Pariser, D.M.; Barber, K.A.; Langley, R.G.; Schlievert, P.M.; Abrams, B.; Hultsch, T.

Source: British Journal of Dermatology, Volume 161, Number 2, August 2009 , pp. 435-443(9)

Publisher: Blackwell Publishing

Pimecrolimus: Molluscum contagiosum in a child: case report

Source: Reactions, Volume 1, Number 1255, 2009-06-06 , pp. 27-27(1)

Publisher: Adis International

The Efficacy of Pimecrolimus 1% Cream Combined with Microdermabrasion in the Treatment of Nonsegmental Childhood Vitiligo: A Randomized Placebo-Controlled Study

Authors: Farajzadeh, Saeedeh; Daraei, Zahra; Esfandiarpour, Iraj; Hosseini, Seyed Hamed

Source: Pediatric Dermatology, Volume 26, Number 3, May/June 2009 , pp. 286-291(6)

Publisher: Blackwell Publishing

Combination of 308-nm Excimer Laser With Topical Pimecrolimus For the Treatment of Childhood Vitiligo

Authors: HUI-LAN, YANG; XIAO-YAN, HUANG; JIAN-YONG, FAN; ZONG-RONG, LIU

Source: Pediatric Dermatology, Volume 26, Number 3, May/June 2009 , pp. 354-356(3)

Publisher: Blackwell Publishing

Impact of Topical Calcineurin Inhibitors on Quality of Life in Patients with Atopic Dermatitis

Authors: Ingram, John R.; Martin, Julie A.; Finlay, Andrew Y.

Source: American Journal of Clinical Dermatology, Volume 10, Number 4, 3 June 2009 , pp. 229-237(9)

Publisher: Adis International